Tallahassee, Fla.-based Baycom Diagnostics has developed A1Care, a cost-effective kit for monitoring and testing for both feline and canine diabetes.
Much like with humans, cases of diabetes in dogs and cats have increased steadily over recent years. According to research released by Vancouver, Wash.-based Banfield Pet Hospital, instances of dog diabetes have increased from 13.1 cases per 10,000 in 2006 to 23.6 cases per 10,000 in 2015—a 79.7 percent jump in less than 10 years.
While previous tests for detecting the disease in dogs and cats have been largely expensive and time consuming, A1Care is neither, the company stated. The test allows veterinarians to mail a patient’s dried blood sample to Baycom’s labs; the sample is analyzed and results are returned to the clinic within two weeks—all with a fee of $49 per test.
“For the vets, it is super easy to use,” said Gus Ray, Baycom’s CEO. “Blood, information, mail, and you’re done. All of the magic happens once we get the sample.”
Ray developed A1Care after he was hired to conduct at-home glycated hemoglobin (A1C) testing for diabetic persons. Initially, he thought the same test could be effective when testing for the disease in dogs and cats, but learned the hemoglobin in animal blood would not yield an accurate glucose reading. Ray continued to develop the product over a four-year period before releasing it in 2016.
A contender for New Product of the Year by the North American Veterinary Community, more than 8,000 A1Care test kits were sold nationwide last year.
3 thoughts on “Florida manufacturer develops rapid animal diabetes testing”
From one of our users: When I first received my A1C test I was excited to see the results. A normal glucose curve had always provided too many variables and was tough to know if the results were true. When I tested my first patient I got a higher than expected number. This dog was supposed to be well regulated. I was able to adjust his dosing and found a much better insulin dose. My second patient was a rather large cat. This cat always had a slightly elevated glucose but was also extremely nervous for exams and sample collection. I ran an A1C and realized that he was indeed a diabetic. My clients and myself have found great value in the A1C test. I will be recommending this for all of my diabetic patients for monitoring and diagnosis.
David Johnston DVM
Wow. That’s a lot like Flexsite Diagnostics that Gus’ father founded and was chief scientist in human A1C. It’s such a shame to see a son run off with his father’s technology without a word of acknowledgement
Hmmm. How can 2 weeks be rapid turn around? Nothing is better than a 12 hr home glucose curve. How else will you know nadir, duration of action and if symogyi occurs?